One hundred fifty-eight consecutive patients with clinically localized prostate cancer were submitted to staging laparoscopic pelvic lymphadenectomy (LPL) at 5 cooperative centers with one or more of the following conditions which were considered as risk factors for nodal disease: clinical stage C (or T3) disease, serum prostate-specific antigen >20 ng/ml, Gleason sum >6. The mean number of lymph nodes removed was 11 (range 2-29). Metastases from prostate cancer were found in 41 patients (25.9 %). The proportion of lymph node-positive patients increases significantly with the presence of one, two or three of the conditions considered as risk factors (p <0.00005). The benefit of LPL is limited to the lymph node-positive patients who can be spared a second operation.
|Number of pages||3|
|Publication status||Published - 1995|
- Laparoscopic pelvic lymphadenectomy
- Multicenter experience
- Prostate cancer staging
ASJC Scopus subject areas